Stevanato Group S.p.A. (NYSE:STVN) Short Interest Down 18.5% in November

Stevanato Group S.p.A. (NYSE:STVN) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling 3,660,000 shares, a decline of 18.5% from the October 31st total of 4,490,000 shares. Currently, 7.4% of the company’s stock are sold short. Based on an average daily volume of 545,200 shares, the days-to-cover ratio is presently 6.7 days.

Analyst Upgrades and Downgrades

Separately, Citigroup lowered their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. nVerses Capital LLC bought a new stake in Stevanato Group during the third quarter worth about $84,000. Hilltop National Bank raised its holdings in Stevanato Group by 34.3% during the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after acquiring an additional 1,122 shares in the last quarter. Harbor Capital Advisors Inc. raised its holdings in Stevanato Group by 109.1% during the second quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after acquiring an additional 4,626 shares in the last quarter. Raymond James Trust N.A. raised its holdings in Stevanato Group by 18.7% during the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after acquiring an additional 1,613 shares in the last quarter. Finally, Hardy Reed LLC raised its holdings in Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares in the last quarter.

Stevanato Group Stock Performance

Stevanato Group stock traded up €0.03 ($0.03) during trading hours on Friday, hitting €20.03 ($21.08). The stock had a trading volume of 144,700 shares, compared to its average volume of 508,631. Stevanato Group has a fifty-two week low of €16.56 ($17.43) and a fifty-two week high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The company has a market cap of $5.92 billion, a PE ratio of 42.62, a price-to-earnings-growth ratio of 9.00 and a beta of 0.58. The company has a 50-day moving average of €19.48 and a two-hundred day moving average of €19.64.

Stevanato Group (NYSE:STVN) last posted its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same period in the previous year, the firm posted $0.16 earnings per share. The firm’s revenue was up 2.4% on a year-over-year basis. On average, equities research analysts anticipate that Stevanato Group will post 0.5 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.